CENTONZE, DIEGO
 Distribuzione geografica
Continente #
NA - Nord America 133.843
EU - Europa 8.739
AS - Asia 3.554
SA - Sud America 65
Continente sconosciuto - Info sul continente non disponibili 59
OC - Oceania 37
AF - Africa 9
Totale 146.306
Nazione #
US - Stati Uniti d'America 133.753
UA - Ucraina 1.791
CN - Cina 1.692
KR - Corea 1.532
IE - Irlanda 1.481
DE - Germania 1.296
IT - Italia 1.252
SE - Svezia 634
GB - Regno Unito 583
FR - Francia 496
FI - Finlandia 379
PL - Polonia 288
RU - Federazione Russa 193
NL - Olanda 121
CA - Canada 70
JP - Giappone 70
EU - Europa 52
BE - Belgio 48
HK - Hong Kong 48
IN - India 43
AU - Australia 33
RO - Romania 32
BG - Bulgaria 31
BR - Brasile 31
IR - Iran 27
CL - Cile 23
SG - Singapore 22
ES - Italia 20
VN - Vietnam 18
KG - Kirghizistan 15
DK - Danimarca 14
DM - Dominica 14
UZ - Uzbekistan 14
CH - Svizzera 10
CZ - Repubblica Ceca 9
GR - Grecia 9
IL - Israele 9
AT - Austria 8
HR - Croazia 8
ID - Indonesia 8
TR - Turchia 8
TW - Taiwan 8
A2 - ???statistics.table.value.countryCode.A2??? 7
PT - Portogallo 7
HU - Ungheria 6
KZ - Kazakistan 6
MY - Malesia 6
AE - Emirati Arabi Uniti 5
AR - Argentina 5
MX - Messico 5
NO - Norvegia 5
SA - Arabia Saudita 5
BD - Bangladesh 4
LT - Lituania 4
NZ - Nuova Zelanda 4
RS - Serbia 4
NG - Nigeria 3
PE - Perù 3
ZA - Sudafrica 3
CO - Colombia 2
EG - Egitto 2
KH - Cambogia 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
LV - Lettonia 2
PH - Filippine 2
SM - San Marino 2
TH - Thailandia 2
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
ET - Etiopia 1
IQ - Iraq 1
JO - Giordania 1
MD - Moldavia 1
MF - Saint Martin 1
MT - Malta 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
VA - Santa Sede (Città del Vaticano) 1
Totale 146.306
Città #
Woodbridge 39.452
Wilmington 38.123
Houston 33.034
Fairfield 4.512
Ann Arbor 3.284
Ashburn 1.865
Chandler 1.795
Seattle 1.786
Jacksonville 1.595
Cambridge 1.539
Dublin 1.427
Medford 1.031
Beijing 594
Dearborn 561
New York 513
Lawrence 489
Rome 391
Zhengzhou 347
Kraków 274
Hangzhou 269
Mülheim 242
San Diego 239
Menlo Park 200
Norwalk 172
Milan 115
Redwood City 107
London 98
San Mateo 85
Mountain View 80
University Park 78
Shanghai 71
Falls Church 69
Guangzhou 65
Saint Petersburg 60
Seoul 59
Verona 59
Palo Alto 57
Hefei 53
Nanjing 52
Detroit 48
Mcallen 45
Brussels 41
Kunming 37
Roebling 37
Toronto 36
Philadelphia 33
Boardman 31
Colorado Springs 31
Nanchang 31
San Francisco 30
Chicago 27
Center 26
Lappeenranta 23
Helsinki 22
Hong Kong 22
São Paulo 22
San Jose 21
Indiana 20
Redmond 19
Southern 19
Hounslow 18
Jinan 17
Kilburn 17
Los Angeles 17
Naples 17
Arosio 16
Creede 16
Nürnberg 16
Tokyo 16
Inverigo 15
Chiswick 14
Hebei 14
New Bedfont 14
Phoenix 14
Pune 14
Roseau 14
Daejeon 13
Dong Ket 13
Prescot 13
Atlanta 12
Chengdu 12
Fuzhou 12
Del Norte 11
Florence 11
Hanover 11
Islington 11
Auburn Hills 10
Wuhan 10
Amsterdam 9
Cagliari 9
Palermo 9
Shenyang 9
Acton 8
Groningen 8
Piove di Sacco 8
Sofia 8
Southwark 8
Bari 7
Catania 7
Genoa 7
Totale 135.948
Nome #
Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression 673
Neurophysiology of synaptic functioning in multiple sclerosis 505
Caspase-8 contributes to angiogenesis and chemotherapy resistance in glioblastoma 494
Cannabinoids therapeutic use: what is our current understanding following the introduction of THC, THC:CBD oromucosal spray and others? 486
Tumor necrosis factor is elevated in progressive multiple sclerosis and causes excitotoxic neurodegeneration 469
Budget Impact Analysis for Peginterferon Beta-1a In Relapsing Remitting Multiple Sclerosis In Italy 469
KFLC Index utility in multiple sclerosis diagnosis: Further confirmation 463
Effects of postural exercises in patients with Parkinson's disease and Pisa syndrome: A pilot study 451
A novel crosstalk within the endocannabinoid system controls GABA transmission in the striatum 449
No evidence of beneficial effects of plasmapheresis in natalizumab-associated PML 447
Abnormal Ca2+-calmodulin-dependent protein kinase II function mediates synaptic and motor deficits in experimental parkinsonism 443
Synaptopathy connects inflammation and neurodegeneration in multiple sclerosis 443
Abnormal mGlu 5 receptor/endocannabinoid coupling in mice lacking FMRP and BC1 RNA 442
Neural stem cell transplantation induces stroke recovery by upregulating glutamate transporter GLT-1 in astrocytes 438
Connectivity Between Posterior Parietal Cortex and Ipsilateral Motor Cortex Is Altered in Schizophrenia 437
Natalizumab discontinuation in patients with multiple sclerosis: Profiling risk and benefits at therapeutic crossroads 434
Subclinical central inflammation is risk for RIS and CIS conversion to MS 434
Growth factors and synaptic plasticity in relapsing-remitting multiple sclerosis 433
Interferon-γ causes mood abnormalities by altering cannabinoid CB1 receptor function in the mouse striatum 433
Genetic variants of the NMDA receptor influence cortical excitability and plasticity in humans 431
A synaptic mechanism underlying the behavioral abnormalities induced by manganese intoxication 431
TRPV1 polymorphisms and risk of interferon β-induced flu-like syndrome in patients with relapsing-remitting multiple sclerosis 431
Muscarinic IPSPs in rat striatal cholinergic interneurones 426
FAS-ligand regulates differential activation-induced cell death of human T-helper 1 and 17 cells in healthy donors and multiple sclerosis patients 426
miR-142-3p Is a Key Regulator of IL-1β-Dependent Synaptopathy in Neuroinflammation 426
Voluntary exercise and sucrose consumption enhance cannabinoid CB1 receptor sensitivity in the striatum 425
Distinct modulation of human myeloid and plasmacytoid dendritic cells by anandamide in multiple sclerosis 425
Abnormal striatal GABA transmission in the mouse model for the fragile X syndrome 422
Hypoglycemia, hypoxia, and ischemia in a corticostriatal slice preparation: electrophysiologic changes and ascorbyl radical formation 421
Neuroinflammation drives anxiety and depression in relapsing-remitting multiple sclerosis 421
Real-world effectiveness of natalizumab and fingolimod compared with self-injectable drugs in non-responders and in treatment-naïve patients with multiple sclerosis 420
Treatment decisions for patients with active multiple sclerosis 419
Type-1 cannabinoid receptors colocalize with caveolin-1 in neuronal cells 418
Neurophysiology of Parkinson's disease: from basic research to clinical correlates 418
Abnormal activity of the Na/Ca exchanger enhances glutamate transmission in experimental autoimmune encephalomyelitis 417
Risk of acute promyelocytic leukemia in multiple sclerosis: coding variants of DNA repair genes 416
The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis. 416
Functional connectivity changes within specific networks parallel the clinical evolution of multiple sclerosis 416
Modulation of monocytes by bioactive lipid anandamide in multiple sclerosis involves distinct Toll-like receptors 416
Chronic cocaine sensitizes striatal GABAergic synapses to the stimulation of cannabinoid CB1 receptors 414
Neuronal vulnerability following inhibition of mitochondrial complex II: a possibile ionic mechanism for Huntington’s disease. 414
The (endo)cannabinoid system in multiple sclerosis and amyotrophic lateral sclerosis 414
RANTES correlates with inflammatory activity and synaptic excitability in multiple sclerosis 414
Siponimod (BAF312) prevents synaptic neurodegeneration in experimental multiple sclerosis 414
Cortical hyperexcitability in post-traumatic stress disorder secondary to minor accidental head trauma: a neurophysiologic study 414
Placebo effects in a multiple sclerosis spasticity enriched clinical trial with the oromucosal cannabinoid spray (THC/CBD): dimension and possible causes 413
Diagnostic tools for assessment of urinary dysfunction in MS patients without urinary disturbances 413
Heart rate variability is differentially altered in multiple sclerosis: implications for acute, worsening and progressive disability 413
Striatal synaptic plasticity: implications for motor learning and Parkinson's disease 411
Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study 411
Abnormal sensitivity to cannabinoid receptor stimulation might contribute to altered gamma-aminobutyric acid transmission in the striatum of R6/2 Huntington's disease mice 410
T helper 9 cells induced by plasmacytoid dendritic cells regulate interleukin-17 in multiple sclerosis 410
Gabaergic and glutamatergic synaptic transmissions are altered after cuprizone exposure: implication for schizophrenia and demyelinating diseases 409
Activation of dopamine D1-like receptors excites LTS interneurons of the striatum 408
Linking synaptopathy and gray matter damage in multiple sclerosis 408
Cost-Effectiveness Analysis of Peginterferon Beta-1a In Italian Relapsing Remitting Multiple Sclerosis Management 408
Interaction between interleukin-1β and type-1 cannabinoid receptor is involved in anxiety-like behavior in experimental autoimmune encephalomyelitis 408
A Substrate Trapping Mutant Form of Striatal-Enriched Protein Tyrosine Phosphatase Prevents Amphetamine-Induced Stereotypies and Long-Term Potentiation in the Striatum 407
The (AAT)n repeat of the cannabinoid CB1 receptor gene influences disease progression in relapsing multiple sclerosis. 407
Lack of effect of cannabis-based treatment on clinical and laboratory measures in multiple sclerosis 407
Multiparametric MR investigation of the motor pyramidal system in patients with 'truly benign' multiple sclerosis 407
The cross-cultural adaptation and psychometric validation of the MSSS-88 for use in Italian patients with multiple sclerosis 407
Determination of κFLC and κ Index in cerebrospinal fluid: a valid alternative to assess intrathecal immunoglobulin synthesis 407
Synaptic transmission in the striatum: from plasticity to neurodegeneration 406
Metabotropic glutamate receptors and striatal synaptic plasticity: implications for neurological diseases 406
Activation of group III metabotropic glutamate receptors depresses glutamatergic transmission at corticostriatal synapse 405
Paroxysmal dysarthria-ataxia syndrome resolving after fingolimod treatment 405
Excitation by dopamine of rat subthalamic nucleus neurones in vitro-a direct action with unconventional pharmacology 403
The endocannabinoid system in the inflammatory and neurodegenerative processes of multiple sclerosis and of amyotrophic lateral sclerosis 403
Interleukin-1β Promotes Long-Term Potentiation in Patients with Multiple Sclerosis 403
Interleukin-1β causes excitotoxic neurodegeneration and multiple sclerosis disease progression by activating the apoptotic protein p53 403
TRPV1 channels facilitate glutamate transmission in the striatum 402
Transcranial direct current stimulation ameliorates tactile sensory deficit in multiple sclerosis 402
Abnormal sensitivity of cannabinoid CB1 receptors in the striatum of mice with experimental amyotrophic lateral sclerosis 401
D-aspartate prevents corticostriatal long-term depression and attenuates schizophrenia-like symptoms induced by amphetamine and MK-801 401
Interleukin-8 is associated with acute and persistent dysfunction after optic neuritis 401
Monomethyl fumarate inhibits the NFkB pathway and pro-inflammatory cytokine expression in microglia through HCA2 signaling via the AMPK/Sirt axis 401
Disability in multiple sclerosis: When synaptic long-term potentiation fails 401
Transient receptor potential vanilloid 1 channels control acetylcholine/2-arachidonoylglicerol coupling in the striatum 400
Disability and its progression can be objectively measured in multiple sclerosis 400
Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia 399
Effects of anodal transcranial direct current stimulation on chronic neuropathic pain in patients with multiple sclerosis 399
The brain cytoplasmic RNA BC1 regulates dopamine D2 receptor-mediated transmission in the striatum 399
Sympathetic autonomic system is differentially altered in progressive and relapsing multiple sclerosis 399
Inflammation inhibits GABA transmission in multiple sclerosis 397
Transcranial direct current stimulation (tdcs) does not produce acute urodynamic changes 397
Transcranial magnetic stimulation primes the effects of exercise therapy in multiple sclerosis 396
Effects of palmitoylation of Cys(415) in helix 8 of the CB(1) cannabinoid receptor on membrane localization and signalling 396
The interplay between inflammatory cytokines and the endocannabinoid system in the regulation of synaptic transmission 396
T regulatory cells are markers of disease activity in multiple sclerosis patients 396
Electrophysiological recordings and calcium measurements in striatal large aspiny interneurons in response to combined O2/glucose deprivation 395
Abnormal brain lateralization and connectivity in schizophrenia 395
Striatal spiny neurons and cholinergic interneurons express differential ionotropic glutamatergic responses and vulnerability: implications for ischemia and Huntington's disease 395
Effects of intermittent theta burst stimulation on spasticity in patients with multiple sclerosis 395
Role of Ca2+ in striatal LTD and LTP 395
GABAergic signaling and connectivity on Purkinje cells are impaired in experimental autoimmune encephalomyelitis 395
K Index in cerebrospinal fluid: a valid tool in multiple sclerosis diagnosis 395
rTMS of supplementary motor area modulates therapy-induced dyskinesias in Parkinson disease 394
Opposite membrane potential changes induced by glucose deprivation in striatal spiny neurons and in large aspiny interneurons 394
Oral fingolimod rescues the functional deficits of synapses in experimental autoimmune encephalomyelitis 394
Totale 41.896
Categoria #
all - tutte 270.510
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 270.510


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20198.410 0 0 0 0 0 0 0 0 0 0 4.205 4.205
2019/202041.031 3.422 3.440 3.029 3.658 3.293 4.408 3.260 3.592 3.748 3.432 2.816 2.933
2020/202124.507 2.677 3.110 2.586 3.089 2.608 2.324 3.575 2.219 632 475 878 334
2021/20224.779 195 341 187 240 109 677 209 201 432 546 226 1.416
2022/20235.959 749 381 335 640 362 1.527 573 321 410 42 455 164
2023/20241.582 271 72 141 114 166 455 157 101 37 64 4 0
Totale 147.889